CMBA
NUVB icon

C.M. Bidwell & Associates’s Nuvation Bio NUVB Stock Holding History

C.M. Bidwell & Associates’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-867
Closed -$1.44K – 565
2023
Q1 		$1.44K Buy
+867
New +$1.76K ﹤0.01% 486

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

C.M. Bidwell & Associates's NUVB Position: Q2 2023 in Review

C.M. Bidwell & Associates sold out of Nuvation Bio (NUVB) in Q2 2023, closing a stake of 867 shares — an estimated $1.44K sold.

C.M. Bidwell & Associates first reported a position in NUVB in Q1 2023 and held it in 1 quarter. The position peaked at $1.44K in Q1 2023. 124 funds tracked by Wall St. Rank hold NUVB as of Q2 2023.

  • C.M. Bidwell & Associates reported no remaining Nuvation Bio position as of Q2 2023 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 867 Nuvation Bio shares in Q2 2023, an estimated $1.44K.
  • C.M. Bidwell & Associates first reported a position in Nuvation Bio in Q1 2023 and held it in 1 quarter.
  • C.M. Bidwell & Associates's Nuvation Bio position peaked at $1.44K in Q1 2023.
  • 124 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2023.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2023, filed 14 Aug 2023.